Cytoreductive Surgery (CRS) is a surgical procedure used to remove cancer cells from the body. It is typically used in combination with other treatments such as chemotherapy and radiation therapy. The goal of CRS is to reduce the number of cancer cells in the body and thereby improve the chances of survival. CRS involves removing the tumor, along with the surrounding tumor tissue and lymph nodes. This is done by making an incision in the skin and cutting away the cancerous tissue. In some cases, the entire organ may need to be removed. This is known as an organ resection. CRS may be used to treat cancer in many different organs, such as the ovaries, lungs, liver, pancreas, and colon. It is most often used for ovarian cancer, but may be used for other types of cancer as well. CRS is a complex procedure and is often used in combination with other treatments. The procedure can be lengthy and the recovery time can be long. The risks associated with CRS include infection, bleeding, and damage to surrounding organs.
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin Khameh, Baylor College of Medicine, United States
Title : Application of thread technology in aesthetic and functional gynecology
Marlen Sulamanidze, Total Charm Clinic, Georgia
Title : Exploitation of sperm agglutination factor derived from Staphylococcus aureus as a putative candidate for vaginal contraception
Vijay Prabha, Panjab University, India
Title : Pregnancy outcome after uterine artery embolization for uterine adenomyosis: A systematic review and meta-analysis
Mohamed M Hosni, London North West University Healthcare NHS Trust, United Kingdom
Title : Endometrial functions in recurrent pregnancy loss
Nicoletta Di Simone, Humanitas University Milan, Italy
Title : The dawn of biological restoration in female pelvic floor and vulvovaginal disorders
Irene Eirini Orfanoudaki, University Hospital, Greece